# A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

> **NCT03015844** · — · AVAILABLE · sponsor: **Northwell Health**

## Conditions studied

- Neuroblastoma
- Pheochromocytoma

## Interventions

- **DRUG:** 131-I-meta-iodobenzylguanidine

## Key facts

- **NCT ID:** NCT03015844
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2024-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03015844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03015844, "A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03015844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*